Shire ViroPharma Inc. v. CSL Behring LLC

BVLaw
Full Text of Court Cases
March 31, 2021

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
Already a subscriber?  Login
This article is also available for purchase.   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
expert testimony
damages, lost profits, patent infringement, royalty rate, daubert, rule 702, reliability, infringement, qualifications
Shire ViroPharma Inc. v. CSL Behring LLC
2021 U.S. Dist. LEXIS 61551; 2021 WL 1227097
US
Federal Court
Delaware
United States District Court
Scott Lassman, Dr. Timothy Craig, Dr. Lisbeth Illum, Nicholas Godici, and Dr. Christine Meyer, Dr. Gregory Bell, Robert Stoll, and Dr. Bernhardt Trout
Goldberg

Summary

In this patent infringement case, the court ruled on a plethora of Daubert/Rule 702 challenges. The opinion provides an exhaustive list of Daubert-related issues that the court ruled on and provides a good tutorial on the real purposes of Daubert.
02 Shire ViroPharma Inc. v. CSL Behring LLC
PDF, Size: 604 KB

See Also

Patent Infringement Case Provides Judge With a Plethora of Daubert Challenges to Rule on

Court Case Digests
March 31, 2021

In this patent infringement case, the court ruled on a plethora of Daubert/Rule 702 challenges. The opinion provides an exhaustive list of Daubert-related issues that the court ruled on and provides a good tutorial on the real purposes of Daubert.